Week in Review: Hansoh In-licenses Endometriosis/Fibroid Therapy in $170 Million Deal By: TalkMarkets August 13, 2022 at 17:15 PM EDT Other funding deals for drug discovery, R&D, gene editing. Read More >> Related Stocks: Hutchmed China Ltd ADR Lianbio ADR